The clinically proven formula pairs NAD+ with its precursors to replenish skin cells and address nine signs of skin aging for healthier, more resilient-looking skin NEW YORK, March 24, 2026 (GLOBE ...
Todd Schlesinger, MD, discusses how new immunotherapies and multidisciplinary care are reshaping treatment approaches for patients with advanced skin cancers. This content was developed independently ...
May 31, 2025 — A phase II clinical trial led by the Alliance for Clinical Trials in Oncology has met its primary endpoint, demonstrating that the combination of avelumab and cetuximab improved ...
A new preclinical study found that inhibiting the enzyme LSD1 can activate the skin’s immune system and suppress tumor growth ...
Incidence is increasing faster than melanoma, with typical presentation in the mid-70s and risk amplified by UV exposure, fair skin, immunosuppression, and MCPyV-associated oncogenesis. Accurate ...
Explore New Cosmetic Dermatology Services in Sarasota Sarasota, United States - March 20, 2026 / The Center for Skin ...
Adjuvant cemiplimab became a category 1 preferred option after surgery and adjuvant RT for extremely high-risk nodal or nonnodal CSCC, supported by C-POST disease-free survival benefit. Extremely high ...
Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results